Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC14A2 antisense RNA 1 (SLC14A2-AS1) is an antisense long non-coding RNA transcribed from the opposite strand of the SLC14A2 (solute carrier family 14 member 2) gene. While many antisense lncRNAs are known to regulate the expression of their corresponding sense genes through diverse mechanisms—including chromatin modification, transcriptional interference, and mRNA stability—there are currently no detailed studies specifically characterizing the function, disease associations, or therapeutic relevance of SLC14A2-AS1 itself. In general, antisense lncRNAs can modulate cellular processes such as proliferation, migration, invasion, and responsiveness to therapy, often in a cancer context[2]. However, SLC14A2-AS1 is not presently recognized as a therapeutic target, nor are there known drugs, biomarkers, or specific disease roles documented for this molecule. The SLC14A2 gene encodes a urea transporter and is a member of the solute carrier (SLC) family[1][4]. However, SLC14A2-AS1 is distinct from the protein-coding SLC14A2 gene and encodes a regulatory RNA rather than a protein. There are many other antisense lncRNAs (such as FOXP4-AS1, HAND2-AS1) with documented roles in cancer and as potential therapeutic targets[2], but no functional or therapeutic data regarding SLC14A2-AS1 specifically are currently available in the public domain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SLC14A2 antisense RNA 1 (SLC14A2-AS1).